FindTrial
Sign In

Study of health problems in newborn babies due to blood group mismatch between mother and baby. (ABO and Rh Incompatibility)

Clinical Profile of ABO and Rh Incompatibility in Neonates - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108102
Enrollment
168
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed ABO or Rh incompatibility based on maternal and neonatal blood grouping. Neonates with clinical jaundice or anemia

Exclusion criteria

Exclusion criteria: Neonates with other associated conditions like sepsis, G6PD deficiency, liver disease that can lead to jaundice. Cases with incomplete data or parents or guardians who are not willing to give consent.

Design outcomes

Primary

MeasureTime frame
ABO incompatibility was more commonly observed than RH incompatibility among neonates. A significant proportion of affected neonates developed hyperbilirubinemia with many requiring phototherapy and a few requiring exchange transfusion. Some neonates also developed anemia. Mortality was observed in a small no of cases during hospital stay.Timepoint: 7 days—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactSham Lohiya

Datta Meghe Institute of Medical Sciences and Research

sham.lohiya19@gmail.com8098842537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026